1. bookVolume 70 (2021): Issue 1 (June 2021)
Journal Details
License
Format
Journal
eISSN
2247-059X
First Published
31 Jan 1951
Publication timeframe
1 time per year
Languages
English
access type Open Access

Multidrug-resistant tuberculosis and diabetes mellitus as a problem of modern medicine

Published Online: 28 May 2022
Volume & Issue: Volume 70 (2021) - Issue 1 (June 2021)
Page range: 26 - 33
Journal Details
License
Format
Journal
eISSN
2247-059X
First Published
31 Jan 1951
Publication timeframe
1 time per year
Languages
English
Abstract

Aims: To carry out a comprehensive retrospective assessment of the prevalence, features and course of treatment of patients with multidrug-resistant tuberculosis (MDR-TB) and diabetes mellitus (DM).

Materials and Methods: Our study is based on a retrospective analysis of statistical data obtained from 762 current and former MDR-TB patients (74% of patients with resistance only to first-line drugs – isoniazid (H) and rifampin (R); 36% with resistance to H, R and second-line drugs) included in the register of tuberculosis (TB) patients from different regions of Ukraine and the Grodno region of the Republic of Belarus between 2015 and 2019.

Results and Discussion: In both groups of the study recurrent TB prevailed: 49 cases (55.7%) of relapse TB compared to 39 cases (44.3%) of primary TB in the main group; 363 cases (53.9%) of relapse TB compared to 311 (46.1%) primary TB in the control group (P < 0.05). The rate of successful treatment in the control group is higher than in the main group (64.7% vs. 61.4%; P < 0.05). A significant difference between the two groups was observed owing to the difference in frequency of treatment, which in the main group has recorded 27.3%, as against 40.3% in the control group (almost two times lower; P < 0.05).

Conclusions: The association between TB and DM increases the morbidity, chemoresistance and proportion of recurrences. Pulmonary TB developed significantly more often in middle-aged patients with type 2 DM with moderate and severe states, with subcompensated form and with a complicated course.

Keywords

1. Al-Rifai RH, Pearson F, Critchley J, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS ONE. 2017;12: e0187967.10.1371/journal.pone.0187967569782529161276Search in Google Scholar

2. Syal K, Srinivasan A, Banerjee D. VDR, RXR, coronin-1 and inter-feron ɤ levels in PBMCs of type-2 diabetes patients: molecular link between diabetes and tuberculosis. Indian Journal of Clinical Biochemistry. 2015;30(3): 323–328.10.1007/s12291-014-0431-7446906426089620Search in Google Scholar

3. Harries AD, Lin Y, Kumar AMV, Satyanarayana S, Zachariah R, Dlodlo RA. How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS? The International Journal of Tuberculosis and Lung Disease. 2018;22: 1117–1126.Search in Google Scholar

4. Koesoemadinata RC, Kranzer K, Livia R, Susilawati N, Annisa J, Soetedjo NNM, et al. Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus. The International Journal of Tuberculosis and Lung Disease. 2018;22: 1088–1094.10.5588/ijtld.17.082730092877Search in Google Scholar

5. Jain KK, Thakuria R, Lokesh S. Prevalence of pulmonary diabetes mellitus in tuberculosis patients attending tertiary care institute. International Medical Journal. 2015;2(4): 245–248.Search in Google Scholar

6. Ruslami R, Aarnoutse RE, Alisjahbana B, van der Ven AJ, Van Crevel R. Implications of the global increase of diabetes for tuberculosis control and patient care. Tropical Medicine and International Health. 2010;12(11): 1289–1299.10.1111/j.1365-3156.2010.02625.x20955495Search in Google Scholar

7. Liu Q, Li W, Xue M, Chen Y, Du X, Wang C, et al. Diabetes mellitus and the risk of multidrug resistant tuberculosis: a meta-analysis. Scientific Reports. 2017;7: 1090.10.1038/s41598-017-01213-5543079728439071Search in Google Scholar

8. American Diabetes Association. Standards of medical care in diabetes-2019 abridged for primary care providers. Clinical Diabetes. 2019;37(1): 11–34.10.2337/cd18-0105633611930705493Search in Google Scholar

9. Semianiv I, Todoriko L, Ieremenchuk I. Prevention of adverse reactions due to pharmacotherapy in MRTB considering polymorphism of glutathione-S-transferase M1 and T1 genes. Europen Respiratory Journal. 2017;49: 60.Search in Google Scholar

10. Todoriko LD. Immunopathogenesis of drug-resistant tuberculosis present position. Tuberculosis Lung Disease HIV-Infection. 2017;3(30): 92–98.Search in Google Scholar

11. World Health Organization. Rapid Communication: key changes to treatment of multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB). August 2018. WHO/CDS/TB/2018.18.Search in Google Scholar

Recommended articles from Trend MD

Plan your remote conference with Sciendo